All Journals > The Journal of Infectious Diseases > 1 April 2007 > Amplified Transmission in Early HIV Infection

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

1 April 2007

Volume 195, Number 7
The Journal of Infectious Diseases 2007;195:951–959
0022-1899/2007/19507-0007$15.00
DOI: 10.1086/512088
MAJOR ARTICLE

High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection

Bluma G. Brenner,1

Michel Roger,2

Jean‐Pierre Routy,3

Daniela Moisi,1

Michel Ntemgwa,1

Claudine Matte,2

Jean‐Guy Baril,4

Réjean Thomas,5

Danielle Rouleau,2

Julie Bruneau,6

Roger Leblanc,7

Mario Legault,8

Cecile Tremblay,9

Hugues Charest,10

Mark A. Wainberg,1 and the

Quebec Primary HIV Infection Study Groupa

1McGill AIDS Centre–Jewish General Hospital, 2Centre Hospitalier de Université de Montréal (CHUM)–Hôpital Notre‐Dame, 3McGill University Health Centre, 4Clinique Médicale du Quartier Latin, 5Clinique Médicale l’Actuel, 6CHUM–Hôpital St. Luc, 7Clinique Médicale Goldberg, LeBlanc, & Rosengren, 8Fonds de la Recherche en Santé du Québec–SIDA Network, 9CHUM–Hôtel Dieu, and 10Institut National de Santé Publique du Québec, Montreal, Canada

Background.A population‐based phylogenetic approach was used to characterize human immunodeficiency virus (HIV)–transmission dynamics in Quebec.

Methods.HIV‐1 pol sequences included primary HIV infections (PHIs; <6 months after seroconversion) from the Quebec PHI cohort (1998–2005; ) and the provincial genotyping program (2001–2005; ). Phylogenetic analysis determined sequence interrelationships among unique PHIs ( ) and infections from untreated ( ) and treated ( ) chronically infected (CI) potential transmitter populations (2001–2005). Clinical features, risk factors, and drug resistance for clustered and nonclustered transmission events were ascertained.

Results.Viruses from 49.4% (293/593) of PHIs cosegregated into 75 transmission chains with 2–17 transmissions/cluster. Half of the clusters included ( ) transmissions, whereas the remainder had transmissions. Maximum periods for onward transmission in clusters were months. Coclustering of untreated and treated CIs with PHIs were infrequent (6.2% and 4.8%, respectively). The ages, viremia, and risk factors were similar for clustered and nonclustered transmission events. Low prevalence of drug resistance in PHI supported amplified transmissions at early stages.

Conclusions.Early infection accounts for approximately half of onward transmissions in this urban North American study. Therapy at early stages of disease may prevent onward HIV transmission.

Received 6 September 2006; accepted 3 October 2006; electronically published 16 February 2007.

Reprints or correspondence: Dr. Mark Wainberg, McGill AIDS Centre, 3755 Cote Ste. Catherine Rd., Montreal, Quebec, Canada H3W 1G4 ().

Cited by

Joanne D. Stekler, Paul D. Swenson, Robert W. Coombs, Joan Dragavon, Katherine K. Thomas, Catherine A. Brennan, Sushil G. Devare, Robert W. Wood, and Matthew R. Golden. (2009) HIV Testing in a High‐Incidence Population: Is Antibody Testing Alone Good Enough?. Clinical Infectious Diseases 49:3, 444-453
Online publication date: 1-Aug-2009.
Peter H Kilmarx. (2009) Global epidemiology of HIV. Current Opinion in HIV and AIDS 4:4, 240-246
Online publication date: 1-Aug-2009.
CrossRef
Sabine Yerly, Thomas Junier, Angèle Gayet-Ageron, Emmanuelle Boffi El Amari, Viktor von Wyl, Huldrych F Günthard, Bernard Hirschel, Evgeny Zdobnov, Laurent Kaiser. (2009) The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection. AIDS 23:11, 1415-1423
Online publication date: 1-Aug-2009.
CrossRef
Peter R. Kerndt, Robert Dubrow, Getahun Aynalem, Kenneth H. Mayer, Curt Beckwith, Robert H. Remien, Hong-Ha M. Truong, Apurva Uniyal, Michael Chien, Ronald A. Brooks, Ofilio R. Vigil, Wayne T. Steward, Michael Merson, Mary Jane Rotheram-Borus, Stephen F. Morin. (2009) Strategies Used in the Detection of Acute/Early HIV Infections. The NIMH Multisite Acute HIV Infection Study: I. AIDS and Behavior
Online publication date: 3-Jul-2009.
CrossRef
Demetre Daskalakis, Richard Silvera, Kyle Bernstein, Dylan Stein, Robert Hagerty, Richard Hutt, Alith Maillard, William Borkowsky, Judith Aberg, Fred Valentine, and Michael Marmor. (2009) Implementation of HIV Testing at 2 New York City Bathhouses: From Pilot to Clinical Service. Clinical Infectious Diseases 48:11, 1609-1616
Online publication date: 1-Jun-2009.
David Pao, Deenan Pillay, Martin Fisher. (2009) Potential impact of early antiretroviral therapy on transmission. Current Opinion in HIV and AIDS 4:3, 215-221
Online publication date: 1-Jun-2009.
CrossRef
Wei Deng, Peng Fu, Linlin Bao, Nicole Vidal, Qiya He, Chuan Qin, Martine Peeters, Eric Delaporte, Jean-Marie Andrieu, Wei Lu. (2009) Molecular epidemiological tracing of HIV-1 outbreaks in Hainan island of southern China. AIDS 23:8, 977-985
Online publication date: 1-Jun-2009.
CrossRef
Maria Teresa Cuevas, Mercedes Muñoz-Nieto, Miguel M Thomson, Elena Delgado, Jose Antonio Iribarren, Gustavo Cilla, Aurora Fernández-García, Juan Miguel Santamaría, María Jesús Lezaun, Laura Jiménez, Leyre Mónica López-Soria, Mercedes Sota, Gerardo Contreras, Rafael Nájera, Lucía Pérez-Alvarez. (2009) HIV-1 Transmission Cluster With T215D Revertant Mutation Among Newly Diagnosed Patients From the Basque Country, Spain. JAIDS Journal of Acquired Immune Deficiency Syndromes 51:1, 99-103
Online publication date: 1-Jun-2009.
CrossRef
Christine Lubinski, Judith Aberg, Arlene D. Bardeguez, Richard Elion, Patricia Emmanuel, Daniel Kuritzkes, Michael Saag, Kathleen E. Squires, Andrea Weddle, Jennifer Rainey, M. Renee Zerehi, J. Fred Ralston, David A. Fleming, David Bronson, Molly Cooke, Charles Cutler, Yul Ejnes, Robert Gluckman, Mark Liebow, Kenneth Musana, Mark E. Mayer, Mark W. Purtle, P. Preston Reynolds, Lavanya Viswanathan, Kevin B. Weiss, and Baligh Yehia. (2009) HIV Policy: The Path Forward—A Joint Position Paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians. Clinical Infectious Diseases 48:10, 1335-1344
Online publication date: 15-May-2009.
David A. M. C. van de Vijver, Inge Derdelinckx, and Charles A. B. Boucher. (2009) Circulating HIV Type 1 Drug Resistance Will Have Limited Impact on the Effectiveness of Preexposure Prophylaxis among Young Women in Zimbabwe. The Journal of Infectious Diseases 199:9, 1310-1317
Online publication date: 1-May-2009.
William C Miller, Peter A Leone, Sandra McCoy, Trang Q Nguyen, Delbert E Williams, Christopher D Pilcher. (2009) Targeted testing for acute HIV infection in North Carolina. AIDS 27:7, 835-843
Online publication date: 1-May-2009.
CrossRef
Marie-Laure Chaix, Diane Descamps, Marc Wirden, Laurence Bocket, Constance Delaugerre, Catherine Tamalet, Veronique Schneider, Jacques Izopet, Bernard Masquelier, Christine Rouzioux, Laurence Meyer, Dominique Costagliola. (2009) Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996–2006 in France. AIDS 23:6, 717-724
Online publication date: 1-Apr-2009.
CrossRef
Linda G Apuzzo, Florin Vaida, Joel E Gallant, Karin B Ernstrom, Susan J Little, Jean-Pierre Routy, Ann C Collier, Brian Conway, Martin H Markowitz, Frederick M Hecht, Bruce D Walker, Elizabeth Connick, Joseph B Margolick. (2009) Tolerability and Efficacy of PI Versus NNRTI-Based Regimens in Subjects Receiving HAART During Acute or Early HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 50:3, 267-275
Online publication date: 1-Apr-2009.
CrossRef
Alison E. Brown, Robert J. Gifford, Jonathan P. Clewley, Claudia Kucherer, Bernard Masquelier, Kholoud Porter, Claudia Balotta, Nicole K. T. Back, Louise Bruun Jorgensen, Carmen de Mendoza, Krishnan Bhaskaran, O. Noel Gill, Anne M. Johnson, and Deenan Pillay, on behalf of the Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) Collaboration. (2009) Phylogenetic Reconstruction of Transmission Events from Individuals with Acute HIV Infection: Toward More‐Rigorous Epidemiological Definitions. The Journal of Infectious Diseases 199:3, 427-431
Online publication date: 1-Feb-2009.
Bernard Masquelier. (2009) Minority drug-resistant HIV-1 variants: transmission and response to antiretroviral therapy. HIV Therapy 3:1, 55-61
Online publication date: 1-Feb-2009.
CrossRef
Nico JD Nagelkerke, Sake J de Vlas, Prabhat Jha, Ma Luo, Francis A Plummer, Rupert Kaul. (2009) Heterogeneity in host HIV susceptibility as a potential contributor to recent HIV prevalence declines in Africa. AIDS 23:1, 125-130
Online publication date: 1-Feb-2009.
CrossRef
Davey M Smith, Susanne J May, Samantha Tweeten, Lydia Drumright, Mary E Pacold, Sergei L Kosakovsky Pond, Rick L Pesano, Yolanda S Lie, Douglas D Richman, Simon DW Frost, Christopher H Woelk, Susan J Little. (2009) A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS 23:2, 225-232
Online publication date: 1-Feb-2009.
CrossRef
Lydia N Drumright, Simon DW Frost. (2009) Sexual networks and the transmission of drug-resistant HIV. Current Opinion in Infectious Diseases 21:6, 644-652
Online publication date: 1-Jan-2009.
CrossRef
Bluma G Brenner, Michel Roger, Daniela D Moisi, Maureen Oliveira, Isabelle Hardy, Reuven Turgel, Hugues Charest, Jean-Pierre Routy, Mark A Wainberg. (2008) Transmission networks of drug resistance acquired in primary/early stage HIV infection. AIDS 22:18, 2509-2515
Online publication date: 1-Dec-2008.
CrossRef
Victor DeGruttola, Susan Little, Robert Schooley. (2008) Controlling the HIV epidemic, without a vaccine!. AIDS 22:18, 2554-2555
Online publication date: 1-Dec-2008.
CrossRef
Jintanat Ananworanich, Nittaya Phanuphak, Mark de Souza, Robert Paris, Miguel Arroyo, Rapee Trichavaroj, Sunee Sirivichayakul, Cecilia Shikuma, Praphan Phanuphak, Jerome H Kim. (2008) Incidence and Characterization of Acute HIV-1 Infection in a High-Risk Thai Population. JAIDS Journal of Acquired Immune Deficiency Syndromes 49:2, 151-155
Online publication date: 1-Nov-2008.
CrossRef
Matthew Kaye, Doris Chibo, Chris Birch. (2008) Phylogenetic Investigation of Transmission Pathways of Drug-Resistant HIV-1 Utilizing Pol Sequences Derived From Resistance Genotyping. JAIDS Journal of Acquired Immune Deficiency Syndromes 49:1, 9-16
Online publication date: 1-Oct-2008.
CrossRef
T. Déirdre Hollingsworth, Roy M. Anderson, and Christophe Fraser. (2008) HIV-1 Transmission, by Stage of Infection. The Journal of Infectious Diseases 198:5, 687-693
Online publication date: 1-Sep-2008.
Mirjam Kretzschmar, Lucas Wiessing. (2008) New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users. AIDS 22:13, 1527-1537
Online publication date: 1-Sep-2008.
CrossRef
Michel Ntemgwa, M. John Gill, Bluma G. Brenner, Daniela Moisi, Mark A. Wainberg. (2008) Discrepancies in Assignment of Subtype/Recombinant Forms by Genotyping Programs for HIV Type 1 Drug Resistance Testing May Falsely Predict Superinfection. AIDS Research and Human Retroviruses 24:7, 995-1002
Online publication date: 1-Aug-2008.
CrossRef
Olivia Peuchant, Rodolphe Thiébaut, Sophie Capdepont, Valérie Lavignolle-Aurillac, Didier Neau, Philippe Morlat, François Dabis, Hervé Fleury, Bernard Masquelier. (2008) Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy. AIDS 22:12, 1417-1423
Online publication date: 1-Aug-2008.
CrossRef
B Gazzard, N Clumeck, A d'Arminio Monforte, JD Lundgren. (2008) Indicator disease-guided testing for HIV – the next step for Europe?. HIV Medicine 9:s2, 34-40
Online publication date: 1-Aug-2008.
CrossRef
Cynthia L. Gay, Myron S. Cohen. (2008) Antiretrovirals to prevent HIV infection: Pre-and postexposure prophylaxis. Current Infectious Disease Reports 10:4, 323-331
Online publication date: 1-Aug-2008.
CrossRef
Linlin Bao, Nicole Vidal, Hua Fang, Wei Deng, Song Chen, Weizhong Guo, Chuan Qin, Martine Peeters, Eric Delaporte, Jean-Marie Andrieu, Wei Lu. (2008) Molecular Tracing of Sexual HIV Type 1 Transmission in the Southwest Border of China. AIDS Research and Human Retroviruses 24:5, 733-742
Online publication date: 1-Jun-2008.
CrossRef
Laith J Abu-Raddad, Ira M Longini. (2008) No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS 22:9, 1055-1061
Online publication date: 1-Jun-2008.
CrossRef
Martin S. Hirsch. (2008) Initiating Therapy: When to Start, What to Use. The Journal of Infectious Diseases 197:s3, S252-S260
Online publication date: 15-May-2008.
Jurgen Vercauteren, Inge Derdelinckx, André Sasse, Marleen Bogaert, Helga Ceunen, Ann De Roo, Stephane De Wit, Koen Deforche, Fedoua Echahidi, Katrien Fransen, Jean-Christophe Goffard, Patrick Goubau, Elodie Goudeseune, Jean-Cyr Yombi, Patrick Lacor, Corinne Liesnard, Michel Moutschen, Denis Pierard, Roeland Rens, Yoeri Schrooten, Dolores Vaira, Annelies van den Heuvel, Bea van der Gucht, Marc van Ranst, Eric van Wijngaerden, Bernard Vandercam, Marc Vekemans, Chris Verhofstede, Nathan Clumeck, Anne-Mieke Vandamme, Kristel van Laethem. (2008) Prevalence and Epidemiology of HIV Type 1 Drug Resistance among Newly Diagnosed Therapy-Naive Patients in Belgium from 2003 to 2006. AIDS Research and Human Retroviruses 24:3, 355-362
Online publication date: 1-Apr-2008.
CrossRef
Sarah Fidler, Julie Fox, Kholoud Porter, Jonathan Weber. (2008) Primary HIV infection: to treat or not to treat?. Current Opinion in Infectious Diseases 21:1, 4-10
Online publication date: 1-Mar-2008.
CrossRef
Cristina Cellerai, Susan J Little, Sabine Kinloch-de Loes. (2008) Treatment of acute HIV-1 infection: are we getting there?. Current Opinion in HIV and AIDS 3:1, 67-74
Online publication date: 1-Feb-2008.
CrossRef
Linda Gelgor, John Kaldor. (2008) Epidemiology of primary HIV-1 infection. Current Opinion in HIV and AIDS 3:1, 4-9
Online publication date: 1-Feb-2008.
CrossRef
Christopher K. Fairley, Glenda Fehler, Sharon R. Lewin, Marian Pitts, Marcus Y. Chen, Catriona S. Bradshaw, Jane S. Hocking. (2008) Sexually transmissible infection and HIV management among men who have sex with men with and without HIV: survey of medical practitioners who are members of the Australasian Society for HIV Medicine. Sexual Health 5:2, 155
Online publication date: 1-Feb-2008.
CrossRef
Shiro Ibe, Junko Hattori, Seiichiro Fujisaki, Urara Shigemi, Saeko Fujisaki, Kayoko Shimizu, Kazuyo Nakamura, Takejiro Kazumi, Yoshiyuki Yokomaku, Naoto Mamiya, Motohiro Hamaguchi, Tsuguhiro Kaneda. (2008) Trend of Drug-Resistant HIV Type 1 Emergence among Therapy-Naive Patients in Nagoya, Japan: An 8-Year Surveillance from 1999 to 2006. AIDS Research and Human Retroviruses 24:1, 7-14
Online publication date: 1-Feb-2008.
CrossRef
Katherine Ahrens, Charlotte K Kent, Robert P Kohn, Giuliano Nieri, Andrew Reynolds, Susan Philip, Jeffrey D Klausner. (2008) HIV Partner Notification Outcomes for HIV-Infected Patients by Duration of Infection, San Francisco, 2004 to 2006. JAIDS Journal of Acquired Immune Deficiency Syndromes 46:4, 479-484
Online publication date: 1-Jan-2008.
CrossRef
Robert M Grant. (2007) Research in situ. Nature Methods 4:11, 887-890
Online publication date: 1-Dec-2007.
CrossRef
Gary R. West, Amy L. Corneli, Kim Best, Katie M. Kurkjian, William Cates Jr.. (2007) Focusing HIV Prevention on Those Most Likely to Transmit the Virus. AIDS Education and Prevention 19:4, 275-288
Online publication date: 1-Sep-2007.
CrossRef
Joanne Stekler and Robert W. Coombs. (2007) Transmitted HIV‐1 Drug Resistance: Are We Seeing Just the Tip of an Epidemiological Iceberg?. The Journal of Infectious Diseases 196:3, 336-338
Online publication date: 1-Aug-2007.
Victor Musiime, Francis Ssali, Hilda Kizito, Cissy Kityo, Peter Mugyenyi. (2007) Need for review of prevention of mother-to-child transmission practice especially in discordant couples: a case of mother-to-child transmission of HIV during breast feeding by a mother who tested HIV negative antenatally. AIDS 21:12, 1658-1659
Online publication date: 1-Aug-2007.
CrossRef
Deenan Pillay and Martin Fisher. (2007) Primary HIV Infection, Phylogenetics, and Antiretroviral Prevention. The Journal of Infectious Diseases 195:7, 924-926
Online publication date: 1-Apr-2007.
  • Potential conflicts of interest: none reported.

    Presented in part: XIV International HIV Drug Resistance Workshop, Quebec City, Canada, 7–11 June 2005 (abstract 112).

    Financial support: Canadian Institutes for Health Research (grant MT‐14738 for resistance genotyping in the Quebec Primary HIV Infection [PHI] cohort study and for research on PHI); Réseau SIDA of the Fonds de la Recherche en Santé du Québec (funds to recruit patients into the Quebec PHI cohort study); Quebec Ministry of Health (funds to the provincial genotypic resistance testing program).

  • Study group members are listed after the text.

Close Popup